SCHEMBL17876186

SCHEMBL17876186

CC1(C)Oc2ccc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)cc2-c2cc(-n3c4ccccc4c4ccccc43)ccc2O1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.35
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
KMT2A Q03164 2/20 0.35
EDNRA P25101 2/20 0.33
EDNRB P24530 1/20 0.33
ATM Q13315 1/20 0.33
AHR P35869 1/20 0.33
GAA P10253 3/20 0.33
NPC1 O15118 2/20 0.33
HCRTR1 O43613 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
ACACA Q13085 1/20 0.32
MEN1 O00255 1/20 0.32
PIK3R2 O00459 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876164 0.95 KDM4E (0.34) MAPTKDM4EALDH1A1HPGDL3MBTL1
SCHEMBL17876119 0.95 KDM4E (0.34) MAPTKDM4EALDH1A1HPGDL3MBTL1
SCHEMBL17877833 0.90 MYC (0.38) MAPTKDM4EALDH1A1GAANPC1
SCHEMBL17876183 0.90 L3MBTL1 (0.37) MAPTKDM4EL3MBTL1MAPK1TDP1
SCHEMBL17876125 0.86 MYC (0.37) MAPTKDM4EALDH1A1EDNRAEDNRB
SCHEMBL17877702 0.86 MYC (0.37) MAPTKDM4EALDH1A1EDNRAEDNRB
SCHEMBL17876215 0.85 KMT2A (0.41) MAPTKDM4EALDH1A1HPGDL3MBTL1
SCHEMBL17876151 0.84 EDNRA (0.36) KDM4EL3MBTL1TDP1EDNRAEDNRB
SCHEMBL17876086 0.84 EDNRA (0.46) MAPTKDM4EALDH1A1HPGDL3MBTL1
SCHEMBL17876121 0.84 EDNRA (0.36) KDM4EL3MBTL1EDNRAEDNRBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MAPT 2144/4885KDM4E 3120/4885ALDH1A1 1061/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MAPT 2144/4885KDM4E 3120/4885ALDH1A1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.